IL138533A0 - Pharmaceutical compositions for prolonged peptide release and preparation method - Google Patents

Pharmaceutical compositions for prolonged peptide release and preparation method

Info

Publication number
IL138533A0
IL138533A0 IL13853399A IL13853399A IL138533A0 IL 138533 A0 IL138533 A0 IL 138533A0 IL 13853399 A IL13853399 A IL 13853399A IL 13853399 A IL13853399 A IL 13853399A IL 138533 A0 IL138533 A0 IL 138533A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
peptide release
prolonged
prolonged peptide
Prior art date
Application number
IL13853399A
Other languages
English (en)
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of IL138533A0 publication Critical patent/IL138533A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL13853399A 1998-03-25 1999-03-22 Pharmaceutical compositions for prolonged peptide release and preparation method IL138533A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803667A FR2776520B1 (fr) 1998-03-25 1998-03-25 Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
PCT/FR1999/000667 WO1999048517A1 (fr) 1998-03-25 1999-03-22 Compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation

Publications (1)

Publication Number Publication Date
IL138533A0 true IL138533A0 (en) 2001-10-31

Family

ID=9524472

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13853399A IL138533A0 (en) 1998-03-25 1999-03-22 Pharmaceutical compositions for prolonged peptide release and preparation method
IL138533A IL138533A (en) 1998-03-25 2000-09-18 Pharmaceutical compositions comprising a peptide salt for prolonged peptide release

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL138533A IL138533A (en) 1998-03-25 2000-09-18 Pharmaceutical compositions comprising a peptide salt for prolonged peptide release

Country Status (19)

Country Link
US (1) US6503534B1 (xx)
EP (1) EP1066049B1 (xx)
JP (1) JP4162381B2 (xx)
AR (1) AR020062A1 (xx)
AT (1) ATE241377T1 (xx)
AU (1) AU756148B2 (xx)
CA (1) CA2324901C (xx)
CZ (1) CZ298941B6 (xx)
DE (1) DE69908326T2 (xx)
DK (1) DK1066049T3 (xx)
ES (1) ES2200507T3 (xx)
FR (1) FR2776520B1 (xx)
HU (1) HU228903B1 (xx)
IL (2) IL138533A0 (xx)
NO (1) NO324621B1 (xx)
PL (1) PL197775B1 (xx)
PT (1) PT1066049E (xx)
RU (1) RU2224538C2 (xx)
WO (1) WO1999048517A1 (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117057D0 (en) * 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
NZ538928A (en) * 2002-09-27 2006-10-27 Zentaris Gmbh Administration form for pharmaceutically active peptides with sustained release of active ingredient, and method for the production thereof
WO2004087102A2 (en) * 2003-03-26 2004-10-14 Teva Pharmaceutical Industries Ltd. A process for preparing a pharmaceutical active ingredient with high specific surface area
EP3025722B1 (en) 2003-10-03 2020-05-27 Thorn BioScience, LLC Process for the synchronization of ovulation for timed breeding without heat detection
CA2550695A1 (en) * 2003-12-16 2005-06-30 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R Glp-1 pharmaceutical compositions
US20090023644A1 (en) * 2004-01-13 2009-01-22 Southard Jeffery L Methods of using cgrp for cardiovascular and renal indications
CA2552677A1 (en) * 2004-01-13 2005-07-28 Vasogenix Pharmaceuticals, Inc. Controlled release cgrp delivery composition for cardiovascular and renal indications
TW200538148A (en) * 2004-01-13 2005-12-01 Vasogenix Pharmaceuticals Inc Methods for treating acute myocardial infarction by administering calcitonin gene related peptide and compositions containing the same
US7772182B2 (en) * 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
GB0428151D0 (en) * 2004-12-22 2005-01-26 Novartis Ag Organic compounds
GB0511269D0 (en) * 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
EP1912724A2 (en) * 2005-07-28 2008-04-23 Global Research Technologies, LLC Removal of carbon dioxide from air
GB0517627D0 (en) 2005-08-30 2005-10-05 Tyco Electronics Ltd Uk Bus-bar and connector
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US8334257B2 (en) 2005-12-20 2012-12-18 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
US20070219811A1 (en) * 2006-03-16 2007-09-20 Kim John S Method for using an internet-based CRM application to create an on-line leads marketplace
ES2447516T3 (es) * 2006-12-21 2014-03-12 Stryker Corporation Formulaciones de liberación sostenida que comprenden cristales BMP-7
EP2142207A4 (en) * 2007-04-04 2013-01-16 Theratechnologies Inc PHARMACEUTICAL FORMULATIONS OF GHRH MOLECULES
TWI539959B (zh) 2008-02-11 2016-07-01 菲瑞茵國際中心股份有限公司 治療轉移階段攝護腺癌的方法
CA2953975C (en) 2008-06-27 2019-11-26 Duke University Therapeutic agents comprising elastin-like peptides
ES2661240T3 (es) 2009-04-23 2018-03-28 Jbs United Animal Health Ii Llc Método y composición para sincronizar el momento de inseminación
KR101795643B1 (ko) 2009-05-01 2017-11-09 훼링 비.브이. 전립선암 치료용 조성물
TW201043221A (en) * 2009-05-06 2010-12-16 Ferring Int Ct Sa Kit and method for preparation of a Degarelix solution
US20110039787A1 (en) * 2009-07-06 2011-02-17 Ferring International Center S.A. Compositions, kits and methods for treating benign prostate hyperplasia
EP2464370B1 (en) 2009-08-14 2017-03-29 Phasebio Pharmaceuticals, Inc. Modified vasoactive intestinal peptides
TWI536999B (zh) * 2010-01-13 2016-06-11 艾普森藥品公司 製備持續釋放生長激素抑制素類似物之醫藥組成物之方法
HUE031113T2 (en) 2010-10-27 2017-06-28 Ferring Bv Procedure for the preparation of Degarelix and its intermediates
EP2447276A1 (en) 2010-10-27 2012-05-02 Ferring B.V. Process for the manufacture of Degarelix and its intermediates
JO3755B1 (ar) 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
CA2873553C (en) 2011-06-06 2020-01-28 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
DE102011114864A1 (de) 2011-10-05 2013-04-11 Acino Ag Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat
CN107569456A (zh) 2012-06-01 2018-01-12 辉凌公司 制造地加瑞克
ES2808409T3 (es) 2012-11-28 2021-02-26 United Ah Ii Llc Método para sincronizar el tiempo de inseminación en cerdas primerizas
EP2823808A1 (en) 2013-07-09 2015-01-14 Ipsen Pharma S.A.S. Pharmaceutical composition for a sustained release of lanreotide
TW201605488A (zh) 2013-10-15 2016-02-16 大塚製藥股份有限公司 用以預防及／或治療多囊腎病之藥物
EP2910255A1 (en) * 2014-02-19 2015-08-26 MedSkin Solutions Dr. Suwelack AG Methods for the production of biopolymers with defined average molecular weight
TW201625218A (zh) * 2014-04-18 2016-07-16 Ｊｂｓ聯合動物保健有限責任公司 製造含ｇｎｒｈ凝膠之方法
EP3139949B1 (en) 2014-05-08 2020-07-29 Phasebio Pharmaceuticals, Inc. Compositions comprising a vip-elp fusion protein for use in treating cystic fibrosis
US10688156B2 (en) 2015-02-09 2020-06-23 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating muscle disease and disorders
WO2020170185A1 (en) * 2019-02-21 2020-08-27 Dr. Reddy’S Laboratories Limited Substantially pure lanreotide or its salt & process thereof
GR1009814B (el) * 2019-07-29 2020-09-11 Φαρματεν Α.Β.Ε.Ε. Φαρμακευτικο σκευασμα που περιλαμβανει ενα πεπτιδιο αναλογο σωματοστατινης
CN110577567A (zh) * 2019-09-03 2019-12-17 杭州诺泰澳赛诺医药技术开发有限公司 一种制备高比表面积活性多肽或蛋白的方法
CN118302211A (zh) * 2021-11-22 2024-07-05 Specgx有限责任公司 可注射缓释药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990013285A1 (en) * 1989-05-01 1990-11-15 Enzytech, Inc. Process for producing small particles of biologically active molecules
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions

Also Published As

Publication number Publication date
EP1066049B1 (fr) 2003-05-28
PL197775B1 (pl) 2008-04-30
DE69908326D1 (de) 2003-07-03
PL343005A1 (en) 2001-07-30
HUP0101545A3 (en) 2001-12-28
FR2776520A1 (fr) 1999-10-01
CA2324901C (fr) 2012-01-24
JP4162381B2 (ja) 2008-10-08
FR2776520B1 (fr) 2000-05-05
AU756148B2 (en) 2003-01-02
DE69908326T2 (de) 2004-03-25
US6503534B1 (en) 2003-01-07
CA2324901A1 (fr) 1999-09-30
RU2224538C2 (ru) 2004-02-27
CZ20003432A3 (cs) 2001-02-14
ATE241377T1 (de) 2003-06-15
PT1066049E (pt) 2003-10-31
AR020062A1 (es) 2002-04-10
NO20004741L (no) 2000-11-22
IL138533A (en) 2006-12-31
NO20004741D0 (no) 2000-09-22
ES2200507T3 (es) 2004-03-01
WO1999048517A1 (fr) 1999-09-30
AU2938499A (en) 1999-10-18
NO324621B1 (no) 2007-11-26
HUP0101545A1 (hu) 2001-11-28
DK1066049T3 (da) 2003-09-29
HU228903B1 (en) 2013-06-28
EP1066049A1 (fr) 2001-01-10
CZ298941B6 (cs) 2008-03-19
JP2002507578A (ja) 2002-03-12

Similar Documents

Publication Publication Date Title
IL138533A0 (en) Pharmaceutical compositions for prolonged peptide release and preparation method
IL123986A0 (en) Antithombotic agents process for their preparation and pharmaceutical compositions comprising them
HUP0203374A3 (en) Sold oral pharmaceutical composition and process for its preparation
IL136938A0 (en) 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HU9800985D0 (en) Retarde polymere compositions for pharmaceutical compositions
HUP0004400A3 (en) Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use
CZ20011518A3 (cs) Farmaceutický prostředek
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
SG79255A1 (en) Pharmaceutical formulations
HUP0104762A3 (en) Pharmaceutical moxifloxacin compositions and process for their preparation
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
HUP0102515A3 (en) Cyclopeptides, process for their preparation, pharmaceutical compositions comprising thereof and their use
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
AU5565099A (en) Pharmaceutical compositions and methods for use
IL123927A (en) Propanolamine derivatives processes for their preparation and pharmaceutical composition comprising them
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
HUP0104985A3 (en) Pharmaceutical levothyroxine compositions and process for their preparation
AP2001002371A0 (en) Streptogramin derivatives preparation and compositions containing them
EG24463A (en) Modified release pharmaceutical composition
HUP0101098A3 (en) Streptogramin derivatives, process for preparation thereof and compositions containing same
EP1127860A4 (en) PYROTECHNIC COMPOSITION AND METHOD FOR MANUFACTURING THE SAME
IL125908A (en) Peptides and pharmaceutical compositions comprising same
ZA9811470B (en) Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation
IL129607A0 (en) Stabilized pharmaceutical compositions based on quinuprisitine and on dalfopristine and their preparation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed